{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:52:08Z","timestamp":1790707928175,"version":"4.1.0"},"reference-count":44,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health with Ricerca Corrente 2021 funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are frequently associated conditions characterized by low-grade inflammation. Very low-calorie ketogenic diet (VLCKD) strategies are commonly used to simultaneously obtain weight loss and an improvement of liver steatosis. We evaluated the efficacy of 8 weeks\u2019 VLCKD in decreasing the white blood cell (WBC) and platelet (PLT) counts, as well as liver steatosis and fibrosis, diagnosed using transient elastography (FibroScan). Metabolic and anthropometric parameters commonly associated with MASLD were also evaluated. This study included 87 participants; 58 women and 29 men aged between 18 and 64 years with overweight (18%) or obesity (82%), but not taking any medication. Anthropometric measurements, bioimpedance analysis, and biochemical assays were performed before and after the dietary intervention. BMI (kg\/m2) (p-value &lt; 0.001), waist circumference (cm) (p-value &lt; 0.001), and fat mass (kg) (p-value &lt; 0.001) were significantly decreased following VLCKD. After VLCKD, the FibroScan parameter CAP (db\/m), which measures the accumulation of fatty liver, significantly decreased (p-value &lt; 0.001), as did liver stiffness (kPA), the FibroScan parameter quantifying liver fibrosis (p-value &lt; 0.05). Seemingly, WBC (p-value &lt; 0.001) and PLT (p-value &lt; 0.001) counts were lowered by VLCKD in the whole group; however, the decrease in WBC and platelet counts were significant only in patients with steatosis (CAP \u2265 215 dB\/m). Fasting blood glucose (p-value &lt; 0.001), insulin (p-value &lt; 0.001), HbA1c (p-value &lt; 0.001), triglycerides (p-value &lt; 0.001), total cholesterol (p-value &lt; 0.001), LDL-cholesterol (p-value &lt; 0.001), HDL-cholesterol (p-value &lt; 0.001); \u03b3GT (p-value &lt; 0.001) blood levels and insulin resistance (as measured by HOMAIR) (p-value &lt; 0.001); and systolic (p-value &lt; 0.001), and diastolic (p-value &lt; 0.001) blood pressure levels, were all significantly lower after VLCKD. In contrast, blood levels of vitamin D were higher following the diet (p-value &lt; 0.001). We conclude that treating subjects with overweight and obesity with VLCKD is followed by a simultaneous reduction in WBCs and platelets, the expression of low-grade inflammation, and of liver steatosis and fibrosis. Therefore, we can hypothesize that VLCKD decreases general and liver low-grade inflammation, thus improving liver health.<\/jats:p>","DOI":"10.3390\/nu15204468","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:59:01Z","timestamp":1697893141000},"page":"4468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity"],"prefix":"10.3390","volume":"15","author":[{"given":"Sara","family":"De Nucci","sequence":"first","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8650-348X","authenticated-orcid":false,"given":"Caterina","family":"Bonfiglio","sequence":"additional","affiliation":[{"name":"Laboratory of Epidemiology and Statistics, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Donvito","sequence":"additional","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Di Chito","sequence":"additional","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cerabino","sequence":"additional","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3817-8643","authenticated-orcid":false,"given":"Roberta","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Sila","sequence":"additional","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-0436","authenticated-orcid":false,"given":"Endrit","family":"Shahini","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Giannuzzi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4675-2075","authenticated-orcid":false,"given":"Pasqua Letizia","family":"Pesole","sequence":"additional","affiliation":[{"name":"Core Facility Biobank, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Coletta","sequence":"additional","affiliation":[{"name":"Core Facility Biobank, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Lanzilotta","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3221-6562","authenticated-orcid":false,"given":"Giuseppina","family":"Piazzolla","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, School of Medicine, University of Bari \u201cAldo Moro\u201d, Piazza Giulio Cesare 11, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cozzolongo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5140-8060","authenticated-orcid":false,"given":"Gianluigi","family":"Giannelli","sequence":"additional","affiliation":[{"name":"Scientific Direction, National Institute of Gastroenterology \u201cSaverio de Bellis\u201d, IRCCS Hospital, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"De Pergola","sequence":"additional","affiliation":[{"name":"Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS \u201cSaverio de Bellis\u201d, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD Prevalence: A Systematic Review and Meta-Analysis. Clin. Gastroenterol","volume":"20","author":"Le","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_2","first-page":"404","article-title":"Epidemiology of non-alcoholic fatty liver disease in Europe: A systematic review and meta-analysis","volume":"34","author":"Cholongitas","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lonardo, A., Leoni, S., Alswat, K.A., and Fouad, Y. (2020). History of Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165888"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes","volume":"12","author":"Valerio","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of Non-Alcoholic and Alcoholic Fatty Liver Diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Oligschlaeger, Y., and Shiri-Sverdlov, R. (2020). NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines, 8.","DOI":"10.3390\/biomedicines8020028"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1002669","DOI":"10.3389\/fnut.2022.1002669","article-title":"Associations between serum biomarkers and Nonalcoholic Liver Disease: Results of a Clinical Study of Mediterranean Patients with Obesity","volume":"9","author":"Castellana","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zupo, R., Castellana, F., Panza, F., Castellana, M., Lampignano, L., Cincione, R.I., Triggiani, V., Giannelli, G., Dibello, V., and Sardone, R. (2021). Non Alcoholic Fatty Liver Disease is positively associated with increased glycated haemoglobin levels in subjects without diabetes. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081695"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24084","DOI":"10.1038\/s41598-021-03583-3","article-title":"A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight","volume":"11","author":"Castellana","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Prevention","volume":"18","author":"Huang","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: Updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rinella, M.E., Lazarus, J.V., Ratziu, V., Francque, S.M., Sanyal, A.J., Kanwal, F., Romero, D., Abdelmalek, M.F., Anstee, Q.M., and Arab, J.P. (2023). A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 101133.","DOI":"10.1016\/j.aohep.2023.101133"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Non-invasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_18","first-page":"9338","article-title":"Role of Diet and Lifestyle Changes in Nonalcoholic Fatty Liver Disease","volume":"20","author":"Nseir","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Battineni, G., Sagaro, G.G., Chintalapudi, N., Amenta, F., Tomassoni, D., and Tayebati, S.K. (2021). Impact of Obesity-induced inflammation on cardiovascular diseases (CVD). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094798"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","article-title":"Hepatic steatosis, lowgrade chronic infammation and hormone\/growth factor\/adipokine imbalance","volume":"16","author":"Tarantino","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0884533617700353","article-title":"Anti-infammatory diet in clinical practice: A review","volume":"32","author":"Ricker","year":"2017","journal-title":"Nutr. Clin. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7339","DOI":"10.3748\/wjg.v20.i23.7339","article-title":"Mediterranean diet and non-alcoholic fatty liver disease: New therapeutic option around the corner?","volume":"20","author":"Sofi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1182\/blood-2013-12-541672","article-title":"Adherence to the Mediterranean diet is associated with lower platelet and leukocyte counts: Results from the Moli-sani study","volume":"123","author":"Bonaccio","year":"2014","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"834153","DOI":"10.1155\/2008\/834153","article-title":"Platelet counts and platelet activation markers in obese subjects","volume":"2008","author":"Justo","year":"2008","journal-title":"Mediat. Inflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000515381","article-title":"European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis","volume":"14","author":"Muscogiuri","year":"2021","journal-title":"Obes. Factis"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12967-021-03221-6","article-title":"VLCKD: A real time safety study in obesity","volume":"20","author":"Barrea","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bruci, A., Tuccinardi, D., Tozzi, R., Balena, A., Santucci, S., Frontani, R., Mariani, S., Basciani, S., Spera, G., and Gnessi, L. (2020). Very low-calorie ketogenic diet: A safe and effective tool for weight loss in patients with obesity and mild kidney failure. Nutrients, 12.","DOI":"10.3390\/nu12020333"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40618-019-01061-2","article-title":"Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: Systematic review and consensus statement from the Italian Society of Endocrinology (SIE)","volume":"42","author":"Infante","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fendo.2020.00607","article-title":"Efficacy of a 2-month very low-calorie ketogenic diet (VLCKD) compared to a standard low-calorie diet in reducing visceral and liver fat accumulation in patients with obesity","volume":"11","author":"Cunha","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e13024","DOI":"10.1111\/obr.13024","article-title":"Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature","volume":"21","author":"Watanabe","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rinaldi, R., De Nucci, S., Castellana, F., Di Chito, M., Giannuzzi, V., Shahini, E., Zupo, R., Lampignano, L., Piazzolla, G., and Triggiani, V. (2023). The Effects of Eight Weeks\u2019 Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity. Nutrients, 15.","DOI":"10.3390\/nu15040825"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Monda, V., Polito, R., Lovino, A., Finaldi, A., Valenzano, A., Nigro, E., Corso, G., Sessa, F., Asmundo, A., and Di Nunno, N. (2020). Short-term physiological effects of a very low-calorie ketogenic diet: Effects on adiponectin levels and inflammatory states. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093228"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Linsalata, M., Russo, F., Riezzo, G., D\u2019attoma, B., Prospero, L., Orlando, A., Ignazzi, A., Di Chito, M., Sila, A., and De Nucci, S. (2023). The effects of a very-low-calorie ketogenic diet on the intestinal barrier integrity and function in patients with obesity: A Pilot Study. Nutrients, 15.","DOI":"10.3390\/nu15112561"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Celano, G., Calabrese, F.M., Riezzo, G., D\u2019attoma, B., Ignazzi, A., Di Chito, M., Sila, A., De Nucci, S., Rinaldi, R., and Linsalata, M. (2023). Effects of a very-low-calorie ketogenic diet on the fecal and urinary volatilome in an obese patient cohort: A preliminary investigation. Nutrients, 15.","DOI":"10.3390\/nu15173752"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clnesp.2019.09.012","article-title":"Equation models developed with bioelectric impedance analysis tools to assess muscle mass: A systematic review","volume":"35","author":"Beaudart","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/07315724.1992.12098245","article-title":"Bioelectrical impedance analysis: A review of principles and applications","volume":"11","author":"Kushner","year":"1992","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1574887109666141216101630","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: Ultrasound and transient elastography","volume":"9","author":"Berzigotti","year":"2014","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"610","DOI":"10.21037\/hbsn-20-787","article-title":"Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity","volume":"10","author":"Eilenberg","year":"2021","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/hepr.13745","article-title":"2-Step PLT16-AST44 method: Simplifed liver fbrosis detection system in patients with non-alcoholic fatty liver disease","volume":"52","author":"Fujimori","year":"2022","journal-title":"Hepatol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhepr.2019.10.001","article-title":"Platelets in chronic liver disease, from bench to bedside","volume":"1","author":"Ramadori","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1160\/th15-06-0487","article-title":"Polyphenol intake is associated with low-grade inflammation, using a novel data analysis from the Moli-sani study","volume":"115","author":"Pounis","year":"2016","journal-title":"Thromb. Haemost."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/20\/4468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:09:43Z","timestamp":1760130583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/20\/4468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":44,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["nu15204468"],"URL":"https:\/\/doi.org\/10.3390\/nu15204468","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,21]]}}}